Company

Onyx Bio

Rocket Ship Rating

Rocket Ship Rating: 89 out of 100

Building a Virtual Immune System

Also known as Onyx

Biotech & therapeutics
AI native

Status: Operatingas of 2026-09-18
Business model: B2B
Headquarters: Berkeley, California, United States

onyx.bio (opens in a new tab)

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

Onyx is building a virtual immune system for faster and safer development of precision medicines.

Funding snapshot

Total raised: $13.3MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
Latest round: Round, $8M2026-02-13

Funding rounds

Round, 2026: $8M2026-02-13, SEC form D sold, 3 investors
Round, 2022: $5.3M2022-01-28, SEC form D sold, 15 investors